Search Results

Filter
  • 1-10 of  2,496 results for ""Carcinoma, Hepatocellular""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

HOXA9 promotes proliferation, metastasis and prevents apoptosis in hepatocellular carcinoma.

  • Authors : Bao G; Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing , 210008, Jiangsu Province, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei , 230022, Anhui Province, China.

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/genetics ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/metabolism

  • Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Sep 18; Vol. 150 (9), pp. 422. Date of Electronic Publication: 2024 Sep 18.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335

Record details

×
Academic Journal

SEC24C suppresses the propagation and chemoresistance of hepatocellular carcinoma by promoting unfolded protein response-related apoptosis.

  • Authors : Tao X; School of Medicine, Southeast University, Nanjing, Jiangsu, China.; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Bioscience trends [Biosci Trends] 2024 Sep 16; Vol. 18 (4), pp. 343-355. Date of Electronic Publication: 2024 Aug 01.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

×
Academic Journal

Thiostrepton as a Potential Therapeutic Agent for Hepatocellular Carcinoma.

  • Authors : Su G; Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products, School of Pharmacy, Yunnan University, Kunming 650500, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 08; Vol. 25 (17). Date of Electronic Publication: 2024 Sep 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Baicalein Targets MAPK9 to Induce Apoptosis of Hepatocellular Carcinoma Cells.

  • Authors : Wang W; Jiangxi University of Chinese Medicine, Nanchang, China.; Department of Nutrition, Naval Medical University, Shanghai, China.

Subjects: Apoptosis*/Apoptosis*/Apoptosis*/drug effects ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2024 Sep; Vol. 104 (3), pp. e14623.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print Cited Medium: Internet ISSN: 1747-0285

Record details

×
Academic Journal

NSC-38270 Exhibits Anti-invasive and Pro-apoptotic Effects on Hepatocellular Carcinoma Huh7 Cells.

  • Authors : Seo J; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.; Park M

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Anticancer research [Anticancer Res] 2024 Sep; Vol. 44 (9), pp. 3857-3866.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Investigation of the effects of Theranekron and Sorafenib treatments on carcinogenesis, apoptosis and biochemical profile in hepatocellular carcinoma in rats.

  • Authors : Vanli S; Ministry of Agriculture and Forestry, Ilgin District Directorate of Agriculture and Forestry, Konya, Turkey.; Kurtoglu F

Subjects: Sorafenib*/Sorafenib*/Sorafenib*/pharmacology ; Apoptosis*/Apoptosis*/Apoptosis*/drug effects ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/chemically induced

  • Source: Toxicology mechanisms and methods [Toxicol Mech Methods] 2024 Sep; Vol. 34 (7), pp. 750-760. Date of Electronic Publication: 2024 Apr 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101134521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells.

  • Authors : Cao J; Xiamen Key Laboratory of Translational Medical of Digestive System Tumor, Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361004, PR China; Department of Thyroid Head and Neck Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314099, PR China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy

  • Source: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Sep; Vol. 55, pp. 101015. Date of Electronic Publication: 2024 Jun 29.Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Correlation with Apoptosis Process through RNA-Seq Data Analysis of Hep3B Hepatocellular Carcinoma Cells Treated with Glehnia littoralis Extract (GLE).

  • Authors : Park MY; Research Institute of Life Science and College of Veterinary Medicine, Gyeongsang National University, Gazwa, Jinju 52828, Republic of Korea.; Lee S

Subjects: Apoptosis*/Apoptosis*/Apoptosis*/drug effects ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 30; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinoma.

  • Authors : Liao S; The Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Wang Q

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Journal of translational medicine [J Transl Med] 2024 Aug 28; Vol. 22 (1), pp. 792. Date of Electronic Publication: 2024 Aug 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

×
Academic Journal

Anti-CTLA-4 treatment suppresses hepatocellular carcinoma growth through Th1-mediated cell cycle arrest and apoptosis.

  • Authors : Morihara H; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Osaka, Japan.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: PloS one [PLoS One] 2024 Aug 06; Vol. 19 (8), pp. e0305984. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  2,496 results for ""Carcinoma, Hepatocellular""